OSX2:XETRA:XETRA-Ossiam US Minimum Variance ESG NR UCITS ETF 1A (EUR) EUR (EUR)

ETF | Others |

Last Closing

USD 314.75

Change

-0.45 (-0.14)%

Market Cap

USD 0.12B

Volume

2.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.47 (+0.88%)

USD 445.28B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.10 (+0.58%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.10 (+0.34%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.20 (+0.70%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.08 (+0.30%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.39 (-0.84%)

USD 102.61B
8R80:XETRA Amundi Index Solutions - Amund..

-2.60 (-1.81%)

USD 98.84B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.31 (+0.59%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.24 (-0.22%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-2.82 (-0.46%)

USD 80.38B

ETFs Containing OSX2:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.37% 64% D 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.37% 64% D 61% D-
Trailing 12 Months  
Capital Gain 18.59% 70% C- 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.59% 69% C- 69% C-
Trailing 5 Years  
Capital Gain 42.00% 64% D 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 42.00% 61% D- 62% D
Average Annual (5 Year Horizon)  
Capital Gain 9.36% 61% D- 61% D-
Dividend Return 9.36% 60% D- 59% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.07% 63% D 70% C-
Risk Adjusted Return 92.99% 81% B- 83% B
Market Capitalization 0.12B 35% F 31% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.